JVTAX
Price
$91.94
Change
+$1.02 (+1.12%)
Updated
Jul 30 closing price
Net Assets
3.62B
WCMNX
Price
$14.74
Change
+$0.20 (+1.38%)
Updated
Jul 30 closing price
Net Assets
50.78M
Interact to see
Advertisement

JVTAX vs WCMNX

JVTAX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
JVTAX vs. WCMNX commentary
Jul 31, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVTAX is a StrongBuy and WCMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVTAX has more cash in the bank: 3.62B vs. WCMNX (50.8M). JVTAX (0.00) and WCMNX (0.00) have matching dividends . JVTAX was incepted earlier than WCMNX: JVTAX (15 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than JVTAX (1.04). WCMNX is a more actively managed with annual turnover of: 89.00 vs. JVTAX (24.00). WCMNX has a lower initial minimum investment than JVTAX: WCMNX (1000) vs JVTAX (2500). JVTAX annual gain was more profitable for investors over the last year : 14.67 vs. WCMNX (11.59). WCMNX return over 5 years is better than : -5.77 vs. JVTAX (-13.66).
JVTAXWCMNXJVTAX / WCMNX
Total Expense Ratio1.041.2484%
Annual Report Gross Expense Ratio1.042.0451%
Fund Existence15 years7 years-
Gain YTD13.8157.306189%
Front Load6%N/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets3.62B50.8M7,128%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.6711.59127%
Returns for 3 years17.8418.0299%
Returns for 5 years-13.66-5.77237%
Returns for 10 years41.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCNI0.280.02
+8.52%
Scinai Immunotherapeutics Ltd.
HSAI16.550.22
+1.35%
Hesai Group American Depositary Share each ADS represents one
BBCP9.840.10
+1.03%
Concrete Pumping Holdings
DECK99.69-3.85
-3.72%
Deckers Outdoor Corp
CSBR5.26-0.22
-4.01%
Champions Oncology